Cargando…
Correction: LRG1 as a novel therapeutic target in eye disease
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170153/ https://www.ncbi.nlm.nih.gov/pubmed/35228692 http://dx.doi.org/10.1038/s41433-022-01988-6 |
_version_ | 1785039177527590912 |
---|---|
author | De Rossi, Giulia Da Vitoria Lobo, Marlene E. Greenwood, John Moss, Stephen E. |
author_facet | De Rossi, Giulia Da Vitoria Lobo, Marlene E. Greenwood, John Moss, Stephen E. |
author_sort | De Rossi, Giulia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10170153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101701532023-05-11 Correction: LRG1 as a novel therapeutic target in eye disease De Rossi, Giulia Da Vitoria Lobo, Marlene E. Greenwood, John Moss, Stephen E. Eye (Lond) Correction Nature Publishing Group UK 2022-02-28 2023-05 /pmc/articles/PMC10170153/ /pubmed/35228692 http://dx.doi.org/10.1038/s41433-022-01988-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction De Rossi, Giulia Da Vitoria Lobo, Marlene E. Greenwood, John Moss, Stephen E. Correction: LRG1 as a novel therapeutic target in eye disease |
title | Correction: LRG1 as a novel therapeutic target in eye disease |
title_full | Correction: LRG1 as a novel therapeutic target in eye disease |
title_fullStr | Correction: LRG1 as a novel therapeutic target in eye disease |
title_full_unstemmed | Correction: LRG1 as a novel therapeutic target in eye disease |
title_short | Correction: LRG1 as a novel therapeutic target in eye disease |
title_sort | correction: lrg1 as a novel therapeutic target in eye disease |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170153/ https://www.ncbi.nlm.nih.gov/pubmed/35228692 http://dx.doi.org/10.1038/s41433-022-01988-6 |
work_keys_str_mv | AT derossigiulia correctionlrg1asanoveltherapeutictargetineyedisease AT davitorialobomarlenee correctionlrg1asanoveltherapeutictargetineyedisease AT greenwoodjohn correctionlrg1asanoveltherapeutictargetineyedisease AT mossstephene correctionlrg1asanoveltherapeutictargetineyedisease |